Page 3 - Otcmkts Hluyy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Otcmkts hluyy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Otcmkts Hluyy Today - Breaking & Trending Today

H. Lundbeck A/S (OTCMKTS:HLUYY) Upgraded to "Buy" by Zacks Investment Research

Zacks Investment Research upgraded shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) from a hold rating to a buy rating in a research note released on Monday, Zacks.com reports. The firm currently has $27.00 price objective on the stock. According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research […] ....

United States , Rexulti Rxulti , Brintellix Trintellix , Abilify Maintena , Jpmorgan Chase Co , Credit Suisse Group , Zacks Investment Research , Get Rating , Suisse Group , North America , H Lundbecka S , Otcmkts Hluyy ,

SVB Leerink Comments on H. Lundbeck A/S's FY2022 Earnings (OTCMKTS:HLUYY)

H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) – Equities research analysts at SVB Leerink upped their FY2022 earnings per share (EPS) estimates for H. Lundbeck A/S in a report released on Thursday, April 21st. SVB Leerink analyst M. Goodman now forecasts that the company will post earnings of $2.16 per share for the year, up […] ....

United States , Rexulti Rxulti , Brintellix Trintellix , Abilify Maintena , Jpmorgan Chase Co , Credit Suisse Group , Zacks Investment Research , Get Rating , Suisse Group , North America , H Lundbecka S , Otcmkts Hluyy , Earnings Estimates , Svb Leerink Llc ,

H. Lundbeck A/S (OTCMKTS:HLUYY) Upgraded to "Hold" at Zacks Investment Research

Zacks Investment Research upgraded shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) from a sell rating to a hold rating in a report released on Tuesday morning, Zacks.com reports. According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the […] ....

Jpmorgan Chase Co , Credit Suisse Group , Zacks Investment Research , Get Rating , Suisse Group , H Lundbecka S , Otcmkts Hluyy ,

Zacks Investment Research Downgrades H. Lundbeck A/S (OTCMKTS:HLUYY) to Sell

H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Friday, Zacks.com reports. According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the […] ....

Jpmorgan Chase Co , Credit Suisse Group , Zacks Investment Research , Get Rating , Suisse Group , H Lundbecka S , Otcmkts Hluyy ,